| Shereilla Hearn, | |
|
3875 Robert C Byrd Dr, Beckley, WV 25801-2964 | |
| (304) 929-4130 | |
| (304) 929-4134 |
| Full Name | Shereilla Hearn |
|---|---|
| Gender | Female |
| Speciality | Counselor |
| Location | 3875 Robert C Byrd Dr, Beckley, West Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083106132 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101Y00000X | Counselor | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Shereilla Hearn, 3875 Robert C Byrd Dr, Beckley, WV 25801-2964 Ph: (304) 929-4130 | Shereilla Hearn, 3875 Robert C Byrd Dr, Beckley, WV 25801-2964 Ph: (304) 929-4130 |
News Archive
The JDRF today said it is encouraged that the Food and Drug Administration (FDA) has issued a draft guidance which appears to lay a foundation for accelerating the development and availability of artificial pancreas technology (AP) that will improve the lives of millions of Americans living with type 1 diabetes.
Seattle Genetics, Inc. announced today the introduction of its sugar engineered antibody (SEA) technology, a novel approach to increasing the potency of monoclonal antibodies through enhanced effector function. The technology will be presented today by Dennis Benjamin, Ph.D., Senior Director, Chemistry, during the Americas Antibody Congress being held in Washington, DC.
The California Endowment issued a report today highlighting the results of a four year initiative created to strengthen the capacity of county juvenile justice systems to provide mental health and other needed services for youth while in custody and in the community.
New research suggests that there is a complex networks of neurons in some youngsters' brains that make them more likely to begin smoking, experimenting with cannabis or consuming large amounts of alcohol.
Dr. Marisa Weiss, president and founder of Breastcancer.org and a breast oncologist in the Philadelphia area submitted a letter to the U.S. Food and Drug Administration prior to the Oncology Drug Advisory Committee (ODAC) meeting to review data for Avastin's use in metastatic HER2-negative breast cancer. In light of today's news that the FDA has recommended removing Avastin's approval to treat breast cancer, Breastcancer.org is making public Dr. Weiss' ODAC letter in its entirety.
› Verified 5 days ago
Ashley White, LCAS Counselor Medicare: Not Enrolled in Medicare Practice Location: 1828 Harper Rd, Beckley, WV 25801 Phone: 043-253-4004 | |
Matthew L Adams, Counselor Medicare: Not Enrolled in Medicare Practice Location: 221 George St, Beckley, WV 25801 Phone: 681-238-6634 | |
Chermette Wright, MSW Counselor Medicare: Not Enrolled in Medicare Practice Location: 221 George St, Beckley, WV 25801 Phone: 681-238-6634 | |
Tanya Renee Ford, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 313 Teel Rd, Beckley, WV 25801 Phone: 304-640-7676 | |
Lori Ann Petry, Counselor Medicare: Not Enrolled in Medicare Practice Location: 25 Mallard Ct, Beckley, WV 25801 Phone: 304-255-7526 Fax: 304-252-2329 | |
Mr. Kyle Eugene Yoder, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 1409 Maxwell Hill Rd, Beckley, WV 25801 Phone: 602-402-4185 |